Section I
2231 – 2240 of 4751
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
(
- Contribution to journal › Article
-
Mark
A systematic analysis of commonly used antibodies in cancer diagnostics
(
- Contribution to journal › Article
-
Mark
Anal carcinoma - Survival and recurrence in a large cohort of patients treated according to Nordic guidelines.
(
- Contribution to journal › Article
-
Mark
Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
(
- Contribution to journal › Article
-
Mark
Glycaemic control in end-of-life care: fundamental or futile?
(
- Contribution to journal › Scientific review
-
Mark
Multimodal Detection of Iron Oxide Nanoparticles in Rat Lymph Nodes Using Magnetomotive Ultrasound Imaging and Magnetic Resonance Imaging
(
- Contribution to journal › Article
-
Mark
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients.
(
- Contribution to journal › Article
-
Mark
Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytoma.
(
- Contribution to journal › Article
-
Mark
An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study
(
- Contribution to journal › Article
-
Mark
Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy - 25 year follow-up of a randomised trial from the South Sweden Breast Cancer Group.
(
- Contribution to journal › Article